Rational molecular design converting fascaplysin derivatives to potent broad-spectrum inhibitors against bacterial pathogens via targeting FtsZ.
Zhao X, Cao X, Qiu H, Liang W, Jiang Y, Wang Q, Wang W, Li C, Li Y, Han B, Tang K, Zhao L, Zhang X, Wang X, Liang H.
Zhao X, et al. Among authors: wang x, wang w, wang q.
Eur J Med Chem. 2024 Apr 15;270:116347. doi: 10.1016/j.ejmech.2024.116347. Epub 2024 Mar 23.
Eur J Med Chem. 2024.
PMID: 38552428